Physician profile
Iris Sanchez
NPI 1508876970
$3,345.05
in general payments reported to CMS, 2019-2025
17 companies · $159 in 2025
The $159 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $649 · 2022: $1,211 · 2023: $927 · 2024: $398 · 2025: $159.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,485.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,484.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $863.15 | 2021-2024 | |
| Pharmacyclics LLC, An Abbvie Company | $552.55 | 2022-2023 | Imbruvica |
| Regeneron Healthcare Solutions, INC. | $351.40 | 2023-2025 | Libtayo |
| Stemline Therapeutics INC. | $225.49 | 2023 | Orserdu, Elzonris |
| Kyowa Kirin, INC. | $173.92 | 2021-2022 | |
| Lilly USA, LLC | $152.40 | 2023-2024 | Mounjaro, Zepbound, Omvoh |
| Novo Nordisk INC | $129.54 | 2022-2024 | Wegovy |
| E.R. Squibb & Sons, L.L.C. | $127.21 | 2024 | Reblozyl |
| Cequr Corporation | $124.64 | 2022 | |
| Celgene Corporation | $121.28 | 2021 | |
| Rigel Pharmaceuticals, INC. | $119.74 | 2021 | |
| Merck Sharp & Dohme LLC | $119.47 | 2023 | Keytruda |
| Pfizer INC. | $111.95 | 2023 | |
| Kite Pharma, INC. | $99.99 | 2021 | |
| Dexcom, INC. | $30.99 | 2025 | Dexcom G6 Transmitter |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $29.66 | 2023 | Inspire |
| Medtronic, INC. | $11.67 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Iris Sanchez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.